DCPH

Deciphera Pharmaceuticals (DCPH)

Deciphera Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DCPH

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/13	19 : 32	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/05/13	19 : 31	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/05/10	20 : 27	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/05/07	06 : 16	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/04/29	20 : 00	Business Wire	Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/04/09	20 : 00	Business Wire	Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/27	21 : 00	Business Wire	Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/21	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/21	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/21	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/15	06 : 06	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/10	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/10	06 : 30	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/07	21 : 52	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/07	21 : 11	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/06	21 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/06	21 : 00	Business Wire	Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/02	06 : 50	Business Wire	Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/02/01	21 : 00	Business Wire	Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/01/19	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/01/19	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/01/19	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/01/19	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/01/19	01 : 13	Business Wire	Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/01/08	21 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/01/08	21 : 00	Business Wire	Deciphera Pharmaceuticals Announces Planned 2024 Corporate Milestones Supporting Evolution to a Self-Sustaining, Multi-Product Company	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/01/05	21 : 00	Business Wire	Deciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical Benefit of QINLOCK® in 2L GIST Patients with Mutations in KIT Exon 11 and 17/18	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2024/01/02	21 : 00	Business Wire	Deciphera Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2023/12/15	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
2023/12/15	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc